摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

脱水长春碱 | 38390-45-3

中文名称
脱水长春碱
中文别名
——
英文名称
3',4'-Anhydrovinblastine
英文别名
4β-acetoxy-3-hydroxy-16-methoxy-vincaleukoblasta-6,3'-diene-23,22'-dioic acid dimethyl ester;3',4'-anhydro-vincaleukoblastine;3',4'-Dehydrovinblastin
脱水长春碱化学式
CAS
38390-45-3
化学式
C46H56N4O8
mdl
——
分子量
793
InChiKey
FFRFGVHNKJYNOV-ZCIMLLHDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.35±0.1 g/cm3(Predicted)
  • 溶解度:
    DMSO(少量)、甲醇(少量)、水(少量)

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    58
  • 可旋转键数:
    10
  • 环数:
    9.0
  • sp3杂化的碳原子比例:
    0.54
  • 拓扑面积:
    134
  • 氢给体数:
    2
  • 氢受体数:
    11

SDS

SDS:4c18a41f8f86ecc67b71c46e0520d8bc
查看

制备方法与用途

产品描述

脱水长春碱是制备长春瑞滨及其可药用盐的重要原料,在酒石酸长春瑞滨化学合成中具有重要意义。

产品用途

脱水长春碱是一种效果极佳的在研主流抗肿瘤药物,其主要通过与细胞有丝分裂G2期的微管蛋白单体结合来抑制微管形成,并促使肿瘤细胞凋亡。该药物常用于治疗非小细胞癌、乳腺癌、卵巢癌、软组织及内脏转移癌和淋巴癌。此外,脱水长春碱还可作为合成长春瑞滨的中间体。

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    脱水长春碱叔丁基过氧化氢三氟乙酸 作用下, 以 四氢呋喃 为溶剂, 生成 长春素
    参考文献:
    名称:
    吲哚和二氢吲哚生物碱的全合成。十七、凯瑟琳与维那脒(catharinine)的全合成
    摘要:
    16,18-二碳甲氧基分裂胺氧化得到环氧化物(6)和烯酰胺(9)。3',4'-脱氢长春碱 (8) 或亮氨酸 (7) 的类似氧化得到天然产物凯瑟琳 (3)。7 或 8 的高锰酸钾氧化得到 3R-羟基维脒(19),而 4'-脱氧鼠李糖苷(29)的类似氧化得到生物碱维脒(4)。
    DOI:
    10.1139/v79-270
点击查看最新优质反应信息

文献信息

  • Biosynthesis of the Indole Alkaloids. Cell-free Systems fromCatharanthus roseus Plants
    作者:James P. Kutney、Lewis S. L. Choi、Toshio Honda、Norman G. Lewis、Toshitsugu Sato、Kenneth L. Stuart、Brian R. Worth
    DOI:10.1002/hlca.19820650716
    日期:1982.11.3
    Cell-free systems from Catharanthus roseus plants are utilized for various studies relating to the biosynthesis of indole alkaloids. Tryptamine (5) and secologanin (6), two fundamental building units, are shown to be incorporated into the alkaloid vindoline (7). In another study, catharanthine (18) and vindoline (7) are utilized by this enzyme system and coupled to the important bisindole biointermediate
    长春花植物的无细胞系统被用于与吲哚生物碱生物合成有关的各种研究。两种形式的基本构建单元-色胺(5)和secologanin(6)已显示已掺入生物碱长春花碱(7)中。在另一项研究中,该酶系统利用了catharanthine (18)和vindoline(7),并与重要的双吲哚生物中间体3',4'-anhydrovinblastine1 (17)偶联。后者又被引入并转化为天然生物碱酸(8),凯瑟琳(9)和长春碱(10),从而提供有关这些复杂分子生物合成的信息。高压液相色谱法对酶混合物的分析揭示了参与18和7偶联的酶。
  • New Insights into the Mechanism and an Expanded Scope of the Fe(III)-Mediated Vinblastine Coupling Reaction
    作者:Hiroaki Gotoh、Justin E. Sears、Albert Eschenmoser、Dale L. Boger
    DOI:10.1021/ja306229x
    日期:2012.8.15
    catharanthine in an Fe(III)-mediated coupling reaction, an examination of the key structural features of catharanthine required for participation in the reaction, and the development of a generalized indole functionalization reaction that bears little structural relationship to catharanthine itself are detailed. In addition to providing insights into the mechanism of the Fe(III)-mediated coupling reaction
    在 Fe(III) 介导的偶联反应中参与长春质的芳香底物范围的定义,参与反应所需的长春质的关键结构特征的检查,以及具有广义吲哚官能化反应的发展与长春质素本身的结构关系很少被详细说明。除了提供对 Fe(III) 介导的长春花碱长春花碱偶联反应机制的见解,表明在酸性性缓冲液中进行的反应可能是自由基介导的,这些研究为制备以前无法获得的长春碱类似物提供了新的机会,并定义了用于合成含吲哚的天然和非天然产物的强大新方法。
  • Triarylaminium Radical Cation Promoted Coupling of Catharanthine with Vindoline: Diastereospecific Synthesis of Anhydrovinblastine and Reaction Scope
    作者:Byron A. Boon、Dale L. Boger
    DOI:10.1021/jacs.9b06968
    日期:2019.9.11
    vindoline is disclosed, enlisting tris(4-bromophenyl)aminium hexachlororantimonate (BAHA, 1.1 equiv) in aqueous 0.05 N HCl/trifluoroethanol (2-10:1) at room temperature (25 °C), that provides anhydrovinblastine in superb yield (85%) with complete control of the newly formed quaternary C16' stereochemistry. A definition of the scope of aromatic substrates that participate with catharanthine in the BAHA-mediated
    公开了一种新的三芳基胺自由基阳离子促进长春花碱文多林的偶联,在室温 (25°C) 下,在 0.05 N HCl/三氟乙醇 (2-10:1) 溶液中加入三(4-溴苯基)胺六氯酸盐(BAHA,1.1 当量) ),以极好的收率 (85%) 提供脱水长春碱,并完全控制新形成的四元 C16' 立体化学。公开了在 BAHA 介导的非对映选择性偶联反应中与长春花碱一起参与的芳香底物的范围的定义,以及参与反应的长春花碱以外的简化吲哚底物的范围,这些底物确定了参与反应所需的关键结构特征,提供了广义的吲哚长春花碱文多林几乎没有结构关系的功能化反应。
  • Process for the preparation of bisindole alkaloid derivatives
    申请人:Indena S.p.A.
    公开号:EP2135872A1
    公开(公告)日:2009-12-23
    A process for the coupling of catharantine and vindoline catalyzed by Laccases is described. The coupling produces anhydrovinblastine and anhydrovinblastine eniminium, which can be transformed to vinblastine or vinorelbine.
    描述了一种由漆酶催化的卡他兰丁和维诺啶偶联的过程。该偶联产生无长春碱和无长春碱亚胺,可以转化为长春碱长春碱
  • Stereoselective Conversion of Anhydrovinblastine into Vinblastine Utilizing an Anti-vinblastine Monoclonal Antibody as a Chiral Mould
    作者:Tatsuya Shirahama、Takeyuki Kohno、Tomohiro Kaijima、Yasuo Nagaoka、Daisuke Morimoto、Kazumasa Hirata、Shinichi Uesato
    DOI:10.1248/cpb.54.665
    日期:——
    Dimeric indole alkaloid, anhydrovinblastine, which can be obtained from catharanthine and vindoline in a high yield, was converted stereoselectively into vinblastine through alternating oxidation-reduction with oxygen and NaBH(3)CN in the presence of anti-vinblastine monoclonal antibody.
    二聚吲哚生物碱脱水长春碱,可以从catharanthine和长春花碱以高收率获得,通过在存在抗长春碱单克隆抗体的情况下,通过与氧气和NaBH(3)CN交替氧化还原,将立体选择性地转化为长春碱
查看更多

同类化合物

长春西醇 长春西碱 长春花胺 长春花碱 长春罗定 长春素 长春磷汀 长春甘酯 长春瑞宾 长春氮芥 长春氟宁酒石酸盐 长春氟宁 长春曲醇酸 长春曲醇 长春新碱 长春匹定硫酸盐 脱水长春碱 脱乙酰基长春碱酰肼 硫酸长春碱 硫酸长春新碱 硫酸长春地辛 硫酸长春地辛 甲酰基-环氧长春碱 二(N-亚乙基长春地辛)二硫醚 O4-去乙酰基-3',4'-二去氢-4'-脱氧-C'-去甲长春花碱 N-去甲基长春碱 N-(O-4-去乙酰基-长春碱-23-酰基)-L-亮氨酸乙酯 N-(4-叠氮基-3-碘水杨酰)-N'-beta-氨基乙基长春地辛 4-去乙酰基长春花碱 3-(((2-((4-叠氮基-2-硝基苯基)氨基)乙基)氨基)羰基)-O4-去乙酰基-3-去(甲氧羰基)-长春花碱 3''-(beta-氯乙基)-2'',4''-二氧代-3,5''-螺恶唑烷-4-去乙酰氧基长春碱 2,5-哌嗪二酮,1,4-二甲基-3-亚甲基- (3'a,4'a)-4'-脱氧-3',4'-环氧-12'-羟基-长春花碱 12'-iodovinblastine 12'-thiomethylvinblastine 20',20'-difluoro-4'-deoxyvinblastine methyl (13S,15R)-13-[(1R,9R,10S,11R,12R,19R)-11-acetyloxy-10-[(cyclobutanecarbonylamino)methyl]-12-ethyl-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaene-13-carboxylate methyl (13S,15R)-13-[(1R,9R,10S,11R,12R,19R)-11-acetyloxy-10-[[(4-chlorobenzoyl)amino]methyl]-12-ethyl-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaene-13-carboxylate methyl (13S,15R)-13-[(1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-10-hydroxy-5-methoxy-10-[[(4-methoxybenzoyl)amino]methyl]-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaene-13-carboxylate methyl (13S,15R)-13-[(1R,9R,10S,11R,12R,19R)-11-acetyloxy-10-[(3,3-dimethylbutanoylamino)methyl]-12-ethyl-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaene-13-carboxylate methyl (13S,15R)-13-[(1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-10-hydroxy-5-methoxy-8-methyl-10-[[(4-nitrobenzoyl)amino]methyl]-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaene-13-carboxylate methyl (13S,15R)-13-[(1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-10-hydroxy-5-methoxy-8-methyl-10-[(3-methylbutanoylamino)methyl]-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaene-13-carboxylate methyl (13S,15R)-13-[(1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-10-[[(4-fluorobenzoyl)amino]methyl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaene-13-carboxylate methyl (13S,15R)-13-[(1R,9R,10S,11R,12R,19R)-11-acetyloxy-10-[(butanoylamino)methyl]-12-ethyl-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaene-13-carboxylate methyl (13S,15R)-13-[(1R,9R,10S,11R,12R,19R)-11-acetyloxy-10-[[(3-chlorobenzoyl)amino]methyl]-12-ethyl-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaene-13-carboxylate methyl (13S,15R)-13-[(1R,9R,10S,11R,12R,19R)-11-acetyloxy-10-[(cyclopropanecarbonylamino)methyl]-12-ethyl-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaene-13-carboxylate methyl (13S,15R)-13-[(1R,9R,10S,11R,12R,19R)-11-acetyloxy-10-[[(2-chlorobenzoyl)amino]methyl]-12-ethyl-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaene-13-carboxylate methyl (13S,15R)-13-[(1R,9R,10S,11R,12R,19R)-11-acetyloxy-10-[(2,2-dimethylpropanoylamino)methyl]-12-ethyl-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaene-13-carboxylate methyl (13S,15R)-13-[(1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-10-hydroxy-5-methoxy-8-methyl-10-[(propanoylamino)methyl]-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaene-13-carboxylate methyl (13S,15R)-13-[(1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-10-hydroxy-5-methoxy-8-methyl-10-[(pyridine-4-carbonylamino)methyl]-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaene-13-carboxylate